Clinical Trial Update: Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares lobeglitazone with pioglitazone as initial triple therapy for type 2 diabetes, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lobeglitazone (lobeglitazone)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN